| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |